Caligan Partners’s Verrica Pharmaceuticals VRCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.9M | Buy |
923,912
+24,617
| +3% | +$130K | 0.94% | 14 |
|
|
2025
Q1 | $3.98M | Buy |
899,295
+156,326
| +21% | +$691K | 0.83% | 14 |
|
|
2024
Q4 | $5.2M | Buy |
+742,969
| New | +$5.2M | 1.32% | 13 |
|
|
2023
Q4 | – | Sell |
-25,959
| Closed | -$1.01M | – | 12 |
|
|
2023
Q3 | $1.01M | Buy |
+25,959
| New | +$1.01M | 0.46% | 9 |
|